Compare ESLA & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESLA | SGA |
|---|---|---|
| Founded | 2021 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.5M | 73.7M |
| IPO Year | N/A | 1994 |
| Metric | ESLA | SGA |
|---|---|---|
| Price | $1.12 | $9.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 28.4K | 12.7K |
| Earning Date | 05-26-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 9.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $124,829,000.00 |
| Revenue This Year | N/A | $6.74 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.65 |
| 52 Week Low | $0.78 | $9.95 |
| 52 Week High | $3.15 | $14.27 |
| Indicator | ESLA | SGA |
|---|---|---|
| Relative Strength Index (RSI) | 33.78 | 28.66 |
| Support Level | $0.99 | N/A |
| Resistance Level | $1.35 | $12.02 |
| Average True Range (ATR) | 0.12 | 0.35 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 4.11 | 5.83 |
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.